Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9847)
All Articles published online
|
Publishing Process of This Article
|
Aug 7, 2013 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Suppiah A, Greenman J. Clinical utility of anti- |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i29/4651.htm |
| Number | Citing Articles |
| 1 |
Julia Butt, William J. Blot, Lauren R. Teras, Kala Visvanathan, Loïc Le Marchand, Christopher A. Haiman, Yu Chen, Ying Bao, Howard D. Sesso, Sylvia Wassertheil-Smoller, Gloria Y. Ho, Lesley F. Tinker, Richard M. Peek, John D. Potter, Timothy L. Cover, Laura H. Hendrix, Li-Ching Huang, Tim Waterboer, Michael Pawlita, Meira Epplein. Antibody Responses to Streptococcus Gallolyticus Subspecies Gallolyticus Proteins in a Large Prospective Colorectal Cancer Cohort Consortium. Cancer Epidemiology, Biomarkers & Prevention 2018; 27(10): 1186 doi: 10.1158/1055-9965.EPI-18-0249
|
| 2 |
Kazutaka Kojima, Junichi Shindoh, Miho Akabane, Ryosuke Umino, Yuta Kobayashi, Satoshi Okubo, Masaji Hashimoto. Usefulness of Serum Anti‐p53 Antibody Measurement in Patients Undergoing Hepatectomy for Colorectal Liver Metastases. World Journal of Surgery 2021; 45(6): 1906 doi: 10.1007/s00268-021-06049-9
|
| 3 |
Zachary R. Fritz, Rene S. Schloss, Martin L. Yarmush, Lawrence J. Williams. HSymM-guided engineering of the immunodominant p53 transactivation domain putative peptide antigen for improved binding to its anti-p53 monoclonal antibody. Bioorganic & Medicinal Chemistry Letters 2021; 51: 128341 doi: 10.1016/j.bmcl.2021.128341
|
| 4 |
Jian-Xiang Shi, Jie-Jie Qin, Hua Ye, Peng Wang, Kai-Juan Wang, Jian-Ying Zhang. Tumor associated antigens or anti-TAA autoantibodies as biomarkers in the diagnosis of ovarian cancer: a systematic review with meta-analysis. Expert Review of Molecular Diagnostics 2015; 15(6): 829 doi: 10.1586/14737159.2015.1035713
|
| 5 |
Andrés F. Cruz-Pacheco, Jennifer Quinchia, Jahir Orozco. Cerium oxide–doped PEDOT nanocomposite for label-free electrochemical immunosensing of anti-p53 autoantibodies. Microchimica Acta 2022; 189(6) doi: 10.1007/s00604-022-05322-5
|
| 6 |
Arjelle Decasa Agupitan, Paul Neeson, Scott Williams, Jason Howitt, Sue Haupt, Ygal Haupt. P53: A Guardian of Immunity Becomes Its Saboteur through Mutation. International Journal of Molecular Sciences 2020; 21(10): 3452 doi: 10.3390/ijms21103452
|
| 7 |
Elena N. Voropaeva, Mikhail I. Voevoda, Tatiana I. Pospelova, Vladimir N. Maksimov. Prognostic impact of the TP53 rs1625895 polymorphism in DLBCL patients. British Journal of Haematology 2015; 169(1): 32 doi: 10.1111/bjh.13237
|
| 8 |
Lauren R. Teras, Susan M. Gapstur, Maret L. Maliniak, Eric J. Jacobs, Ted Gansler, Angelika Michel, Michael Pawlita, Tim Waterboer, Peter T. Campbell. Prediagnostic Antibodies to Serum p53 and Subsequent Colorectal Cancer. Cancer Epidemiology, Biomarkers & Prevention 2018; 27(2): 219 doi: 10.1158/1055-9965.EPI-17-0407
|
| 9 |
Karīna Siliņa, Undīne Rulle, Zane Kalniņa, Aija Linē. Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?. Cancer Immunology, Immunotherapy 2014; 63(7): 643 doi: 10.1007/s00262-014-1544-9
|
| 10 |
Xiaohui Sun, Xiao-Ou Shu, Qing Lan, Monika Laszkowska, Qiuyin Cai, Nathaniel Rothman, Wanqing Wen, Wei Zheng, Xiang Shu. Prospective Proteomic Study Identifies Potential Circulating Protein Biomarkers for Colorectal Cancer Risk. Cancers 2022; 14(13): 3261 doi: 10.3390/cancers14133261
|
| 11 |
Hao Sun, Jian-Xiang Shi, Hong-Fei Zhang, Meng-Tao Xing, Pei Li, Li-Ping Dai, Cheng-Lin Luo, Xiao Wang, Peng Wang, Hua Ye, Liu-Xia Li, Jian-Ying Zhang. Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer. Tumor Biology 2017; 39(6): 101042831769913 doi: 10.1177/1010428317699132
|
| 12 |
Yu Hong, Jian Huang. Autoantibodies against tumor-associated antigens for detection of hepatocellular carcinoma. World Journal of Hepatology 2015; 7(11): 1581-1585 doi: 10.4254/wjh.v7.i11.1581
|
| 13 |
K. Walczak, J. Olszewski, K. Domeradzka- Gajda, P. Politański, M. Zmyślony, K. Kowalczyk, M. Stępnik. Micronuclei frequency in peripheral blood lymphocytes and levels of anti-p53 autoantibodies in serum of residents of Kowary city regions (Poland) with elevated indoor concentrations of radon. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2019; 838: 67 doi: 10.1016/j.mrgentox.2018.12.007
|
| 14 |
Hans Raskov, Hans-Christian Pommergaard, Jakob Burcharth, Jacob Rosenberg. Colorectal carcinogenesis-update and perspectives. World Journal of Gastroenterology 2014; 20(48): 18151-18164 doi: 10.3748/wjg.v20.i48.18151
|
| 15 |
Koji Hontani, Takahiro Tsuchikawa, Takaki Hiwasa, Toru Nakamura, Takashi Ueno, Toshihiro Kushibiki, Mizuna Takahashi, Kazuho Inoko, Hironobu Takano, Satoshi Takeuchi, Hirotoshi Dosaka-Akita, Masaki Kuwatani, Naoya Sakamoto, Yutaka Hatanaka, Tomoko Mitsuhashi, Hideaki Shimada, Toshiaki Shichinohe, Satoshi Hirano. Identification of novel serum autoantibodies against EID3 in non-functional pancreatic neuroendocrine tumors. Oncotarget 2017; 8(63): 106206 doi: 10.18632/oncotarget.22175
|
| 16 |
Asmaa M. El-Rasikh, Haithem A. M. Farghali, Hisham A. Abdelrahman, Mostafa Elgaffary, Shaymaa Abdelmalek, Ibrahim A. Emam, Magdy A. Ghoneim, Salah A. Selim. The implication of autoantibodies in early diagnosis and monitoring of plasmonic photothermal therapy in the treatment of feline mammary carcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-89894-x
|
| 17 |
Saptaka Baruah, Bidyarani Maibam, Sanjeev Kumar. Biosensor Based Advanced Cancer Diagnostics. 2022; : 257 doi: 10.1016/B978-0-12-823424-2.00023-5
|
| 18 |
Benjamin A. Katchman, Rodrigo Barderas, Rizwan Alam, Diego Chowell, Matthew S. Field, Laura J. Esserman, Garrick Wallstrom, Joshua LaBaer, Daniel W. Cramer, Michael A. Hollingsworth, Karen S. Anderson. Proteomic mapping of p53 immunogenicity in pancreatic, ovarian, and breast cancers. PROTEOMICS – Clinical Applications 2016; 10(7): 720 doi: 10.1002/prca.201500096
|
| 19 |
Feng Zhao, Mei Cao, Xiao-Hui Jiang, Ke Xie, Shang-Rong Ye, Shang-Mian Yie. A specific autoantibody against a novel tumour-association antigen derived from human DNA-topoiomerase I is a potential biomarker for early diagnosis and favourable prognosis in patients with colorectal carcinoma. Biomarkers 2020; 25(2): 149 doi: 10.1080/1354750X.2020.1714734
|
| 20 |
Shinya Abe, Kazushige Kawai, Soichiro Ishihara, Hiroaki Nozawa, Keisuke Hata, Tomomichi Kiyomatsu, Toshiaki Tanaka, Takeshi Nishikawa, Kensuke Ootani, Koji Yasuda, Koji Murono, Toshiaki Watanabe. Prognostic Value of Pre- and Postoperative Anti-p53 Antibody Levels in Colorectal Cancer Patients: A Retrospective Study. Oncology 2017; 92(1): 31 doi: 10.1159/000449527
|
| 21 |
Isabel K. Macdonald, Celine B. Parsy-Kowalska, Caroline J. Chapman. Autoantibodies: Opportunities for Early Cancer Detection. Trends in Cancer 2017; 3(3): 198 doi: 10.1016/j.trecan.2017.02.003
|
| 22 |
Maja Sirotković-Skerlev, Natalija Dedić Plavetić, Filip Sedlić, Sanja Kusačić Kuna, Damir Vrbanec, Borislav Belev, Stjepko Pleština, Zdenko Kovač, Ana Kulić. Prognostic value of circulating Bcl-2 and anti-p53 antibodies in patients with breast cancer: A long term follow-up (17.5 years). Cancer Biomarkers 2021; 30(1): 95 doi: 10.3233/CBM-201497
|
| 23 |
María Garranzo-Asensio, Ana Guzmán-Aránguez, Carmen Povés, María Jesús Fernández-Aceñero, Ana Montero-Calle, María Ángeles Ceron, Servando Fernandez-Diez, Nuria Rodríguez, Marta Gómez de Cedrón, Ana Ramírez de Molina, Gemma Domínguez, Rodrigo Barderas. The specific seroreactivity to ∆Np73 isoforms shows higher diagnostic ability in colorectal cancer patients than the canonical p73 protein. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49960-x
|
| 24 |
Claudia Curcio, Silvia Brugiapaglia, Sara Bulfamante, Laura Follia, Paola Cappello, Francesco Novelli. The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer. Molecules 2021; 26(6): 1642 doi: 10.3390/molecules26061642
|
| 25 |
Anke Vanderstraeten, Tina Everaert, Rieta Van Bree, Godelieve Verbist, Cathérine Luyten, Frederic Amant, Sandra Tuyaerts. In Vitro Validation of Survivin as Target Tumor-associated Antigen for Immunotherapy in Uterine Cancer. Journal of Immunotherapy 2015; 38(6): 239 doi: 10.1097/CJI.0000000000000085
|
| 26 |
Chenguang Li, Mingxiao Chen, Pingwei Zhao, Desalegn Admassu Ayana, Lei Wang, Yanfang Jiang. Expression of MCRS1 and MCRS2 and their correlation with serum carcinoembryonic antigen in colorectal cancer. Experimental and Therapeutic Medicine 2016; 12(2): 589 doi: 10.3892/etm.2016.3424
|
| 27 |
Hualin Fu, Daxiang Cui. Gastric Cancer Prewarning and Early Diagnosis System. Translational Medicine Research 2017; : 11 doi: 10.1007/978-94-024-0951-2_2
|
| 28 |
Mengtao Xing, Xinzhi Wang, Robert Kirken, Ling He, Jian-Ying Zhang. Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment. International Journal of Molecular Sciences 2021; 22(11): 6139 doi: 10.3390/ijms22116139
|
| 29 |
Ryuma Tokunaga, Yasuo Sakamoto, Shigeki Nakagawa, Naoya Yoshida, Hideo Baba. The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatment. Surgery Today 2017; 47(5): 636 doi: 10.1007/s00595-016-1464-8
|
| 30 |
Hugo de Jonge, Luisa Iamele, Maristella Maggi, Greta Pessino, Claudia Scotti. Anti-Cancer Auto-Antibodies: Roles, Applications and Open Issues. Cancers 2021; 13(4): 813 doi: 10.3390/cancers13040813
|
| 31 |
Koji Numata, Manabu Shiozawa, Yukari Ono, Kenta Iguchi, Mamoru Uchiyama, Masahiro Asari, Yasushi Rino, Aya Saito. Clinical Significance of the Post/Preoperative Anti-p53 Antibody Ratio in Predicting the Prognosis of Patients with Colorectal Cancer after Curative Surgery and Its Usefulness in Combination with Carcinoembryonic Antigen. Oncology 2024; : 1 doi: 10.1159/000537963
|
| 32 |
Marica Garziera, Marcella Montico, Ettore Bidoli, Simona Scalone, Roberto Sorio, Giorgio Giorda, Emilio Lucia, Giuseppe Toffoli, Hiromu Suzuki. Prognostic Role of Serum Antibody Immunity to p53 Oncogenic Protein in Ovarian Cancer: A Systematic Review and a Meta-Analysis. PLOS ONE 2015; 10(10): e0140351 doi: 10.1371/journal.pone.0140351
|
| 33 |
Yang Li, Cheng-qiang Li, Shu-juan Guo, Wei Guo, He-wei Jiang, He-cheng Li, Sheng-ce Tao. Longitudinal serum autoantibody repertoire profiling identifies surgery-associated biomarkers in lung adenocarcinoma. EBioMedicine 2020; 53: 102674 doi: 10.1016/j.ebiom.2020.102674
|
| 34 |
Isamu Hoshino, Yoshihiro Nabeya, Nobuhiro Takiguchi, Hisashi Gunji, Fumitaka Ishige, Yosuke Iwatate, Fumiaki Shiratori, Satoshi Yajima, Rei Okada, Hideaki Shimada. Prognostic impact of p53 and/or NY‐ESO‐1 autoantibody induction in patients with gastroenterological cancers. Annals of Gastroenterological Surgery 2020; 4(3): 275 doi: 10.1002/ags3.12325
|
| 35 |
Henry A. Adeola, Muneerah Smith, Lisa Kaestner, Jonathan M. Blackburn, Luiz F. Zerbini. Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort. Oncotarget 2016; 7(12): 13945 doi: 10.18632/oncotarget.7359
|
| 36 |
Satoshi Yajima, Takashi Suzuki, Yoko Oshima, Fumiaki Shiratori, Kimihiko Funahashi, Shinichi Kawai, Toshihiro Nanki, Sei Muraoka, Yoshihisa Urita, Yoshihisa Saida, Shinichi Okazumi, Yuko Kitagawa, Yuki Hirata, Hirotoshi Hasegawa, Koji Okabayashi, Masahiko Murakami, Takeshi Yamashita, Rei Kato, Hisahiro Matsubara, Kentaro Murakami, Yasuaki Nakajima, Hironobu Sugita, Martin Klammer, Hideaki Shimada. New Assay System Elecsys Anti-p53 to Detect Serum Anti-p53 Antibodies in Esophageal Cancer Patients and Colorectal Cancer Patients: Multi-institutional Study. Annals of Surgical Oncology 2021; 28(7): 4007 doi: 10.1245/s10434-020-09342-4
|
| 37 |
Simone Werner, Friedemann Krause, Vinzent Rolny, Matthias Strobl, David Morgenstern, Christian Datz, Hongda Chen, Hermann Brenner. Evaluation of a 5-Marker Blood Test for Colorectal Cancer Early Detection in a Colorectal Cancer Screening Setting. Clinical Cancer Research 2016; 22(7): 1725 doi: 10.1158/1078-0432.CCR-15-1268
|
| 38 |
Takashi Suzuki, Yoko Oshima, Fumiaki Shiratori, Tatsuki Nanami, Satoshi Yajima, Makoto Sumazaki, Mitsunori Ushigome, Hironobu Sugita, Magdalena Eberl, Hideaki Ogata, Tetsu Hayashida, Seigo Nakamura, Tsuyoshi Nakagawa, Hideaki Shimada. Comparison between a new assay system, Elecsys® Anti‑p53, and conventional MESACUP™ for the detection of serum anti‑p53 antibodies: A multi‑institutional study. Molecular and Clinical Oncology 2022; 17(2) doi: 10.3892/mco.2022.2563
|
| 39 |
Hiroki Osumi, Eiji Shinozaki, Mitsukuni Suenaga, Yosuke Kumekawa, Mariko Ogura, Masato Ozaka, Satoshi Matsusaka, Keisho Chin, Noriko Yamamoto, Nobuyuki Mizunuma. Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1751-6
|
| 40 |
Makoto Kobayashi, Hiroyuki Katayama, Johannes F. Fahrmann, Samir M. Hanash. Development of autoantibody signatures for common cancers. Seminars in Immunology 2020; 47: 101388 doi: 10.1016/j.smim.2020.101388
|
| 41 |
Hiroaki Nozawa, Soichiro Ishihara, Kazushige Kawai, Koji Murono, Koji Yasuda, Kensuke Otani, Takeshi Nishikawa, Toshiaki Tanaka, Tomomichi Kiyomatsu, Keisuke Hata, Toshiaki Watanabe. Paradoxical Reductions in Serum Anti-p53 Autoantibody Levels by Chemotherapy in Unresectable Colorectal Cancer: An Observational Study. Oncology 2016; 91(3): 127 doi: 10.1159/000447241
|
| 42 |
Cristovao F. Lima, Marta Costa, M.F. Proença, Cristina Pereira-Wilson. Novel structurally similar chromene derivatives with opposing effects on p53 and apoptosis mechanisms in colorectal HCT116 cancer cells. European Journal of Pharmaceutical Sciences 2015; 72: 34 doi: 10.1016/j.ejps.2015.02.019
|
| 43 |
Tino W. Sanchez, Guangyu Zhang, Jitian Li, Liping Dai, Saied Mirshahidi, Nathan R. Wall, Clayton Yates, Colwick Wilson, Susanne Montgomery, Jian-Ying Zhang, Carlos A. Casiano. Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins. Molecular & Cellular Proteomics 2016; 15(12): 3564 doi: 10.1074/mcp.M116.060244
|
| 44 |
Rongqin Meng, Yang Wang, Liang He, Yuanqing He, Zedong Du. Potential diagnostic value of serum p53 antibody for detecting colorectal cancer: A meta-analysis. Oncology Letters 2018; doi: 10.3892/ol.2018.8070
|